Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Number of holders
-
55
-
Total 13F shares, excl. options
-
15.4M
-
Shares change
-
-193K
-
Total reported value, excl. options
-
$157M
-
Value change
-
-$9.73M
-
Number of buys
-
36
-
Number of sells
-
-15
-
Price
-
$10.19
Significant Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q4 2021
64 filings reported holding VINC - Vincerx Pharma, Inc. - Common Stock as of Q4 2021.
Vincerx Pharma, Inc. - Common Stock (VINC) has 55 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.4M shares
.
Largest 10 shareholders include SAGE RHINO CAPITAL LLC (1.62M shares), Rubric Capital Management LP (1.59M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (1.38M shares), Affinity Asset Advisors, LLC (1.14M shares), TANG CAPITAL MANAGEMENT LLC (1.03M shares), Rock Springs Capital Management LP (809K shares), BlackRock Inc. (772K shares), Holocene Advisors, LP (758K shares), RTW INVESTMENTS, LP (741K shares), and SPHERA FUNDS MANAGEMENT LTD. (720K shares).
This table shows the top 55 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.